Invention Grant
- Patent Title: Glutamate treatment of cardiovascular disorders
-
Application No.: US15686727Application Date: 2017-08-25
-
Publication No.: US10398668B2Publication Date: 2019-09-03
- Inventor: Sunny Po
- Applicant: The Board of Regents of the University of Oklahoma
- Applicant Address: US OK Norman
- Assignee: The Board of Regents of the University of Oklahoma
- Current Assignee: The Board of Regents of the University of Oklahoma
- Current Assignee Address: US OK Norman
- Agency: Dunlap Codding, P.C.
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/51 ; A61K33/06 ; A61K9/50 ; A61K9/08 ; A61K31/197 ; A61K41/00 ; A61K33/02 ; A61N2/00 ; B82Y5/00
Abstract:
Compositions and methods for treating various cardiovascular disorders include targeted delivery of glutamate for impairing a targeted portion of the autonomic nervous system (ANS). Targeted delivery may be via direct injection into the targeted portion of the ANS or via vascular injection of magnetically-targetable nanoparticles.
Public/Granted literature
- US20170348264A1 Glutamate Treatment of Cardiovascular Disorders Public/Granted day:2017-12-07
Information query
